Challenge
A leading biopharma company faced escalating CRO costs and inconsistent quality under a fully outsourced model. Leadership sought a more flexible sourcing strategy balancing internal capability with specialized partner engagement. Scimitar was engaged to redefine the sourcing vision, governance model, and partner selection criteria.
Approach
Through executive workshops and SME interviews, Scimitar benchmarked functional models, developed quantitative scoring tools, and mapped core versus external activities. The team produced a digital playbook, future-state process maps, and comprehensive cost modeling to guide the transition to a blended FSO–FSP–internal structure.
Impact
The new hybrid sourcing framework yielded 20% cost savings, accelerated internal capability builds, and strengthened vendor governance. Implementation plans were fully endorsed by executive leadership, establishing a scalable sourcing ecosystem with improved efficiency, accountability, and cross-functional transparency.
